MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Repro-Med Systems Company Profile (NASDAQ:REPR)

Consensus Ratings for Repro-Med Systems (NASDAQ:REPR) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Repro-Med Systems (NASDAQ:REPR)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings History for Repro-Med Systems (NASDAQ:REPR)
No earnings announcements for this company have been tracked by MarketBeat.com

Earnings Estimates for Repro-Med Systems (NASDAQ:REPR)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Repro-Med Systems (NASDAQ:REPR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Repro-Med Systems (NASDAQ:REPR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
4/11/2016Joseph M Jr. MankoMajor ShareholderBuy15,000$0.31$4,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/16/2016Joseph M Jr. MankoMajor ShareholderBuy21,900$0.45$9,855.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/1/2016Joseph M Jr. MankoMajor ShareholderBuy28,800$0.45$12,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/28/2016Joseph M Jr. MankoMajor ShareholderBuy37,345$0.41$15,311.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2016Joseph M Jr. MankoMajor ShareholderBuy34,500$0.42$14,490.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2016Joseph M Jr. MankoMajor ShareholderBuy44,934$0.41$18,422.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/16/2013Remo SpagnoliDirectorBuy10,000$0.22$2,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Repro-Med Systems (NASDAQ:REPR)
DateHeadline
06/28/16 10:54 AMRepro-Med Systems, Inc. : RMS Medical Products Posts First Quarter 2017 Results
06/27/16 04:25 PMREPRO MED SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh -
06/27/16 02:18 PMRMS Medical Products Posts First Quarter 2017 Results - [Accesswire] - Double digit growth in revenue and adjusted EBITDA the result of accelerated sales and marketing efforts both domestically and international Hosting first International Distributor Meeting in Europe Continued ...
05/19/16 01:30 PMRepro-Med Systems, Inc. :REPR-US: Earnings Analysis: Q4, 2016 By the Numbers -
05/18/16 04:29 PMRepro Med Systems, Inc. Posts Fourth Quarter and Fiscal Year 2016 Results and Announces New Member of the Board of Directors - [PR Newswire] - CHESTER, N.Y., May 18, 2016 /PRNewswire/ -- Repro Med Systems, Inc. dba RMS Medical Products (REPR) today announced its financial results for the fourth quarter and fiscal year ended February 29, 2016.
05/18/16 04:26 PMREPRO MED SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statemen -
03/31/16 03:15 PMREPRO MED SYSTEMS : Other Events, Financial Statements and Exhibits (form 8-K) - 2015 REPRO-MED SYSTEMS, INC.: Repro Med Systems, Inc. Posts Strong Revenue Growth an.. 2015 OTC MARKETS: Welcomes Repro Med Systems to OTCQX 2015 OTC MARKETS: Welcomes Repro Med Systems to OTCQX 2015 REPRO-MED SYSTEMS, INC.: Repro Med Systems, Inc ...
03/31/16 02:03 PMREPRO MED SYSTEMS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
03/31/16 08:43 AMRepro Med Systems, Inc. Gives Business Update Including Preliminary Revenue Results for Q4 2016 - [Accesswire] - CHESTER, NY / ACCESSWIRE / March 31, 2016 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) announced that fourth quarter preliminary net revenues will exceed $3.2 million, representing ...
03/30/16 03:08 PMMorning Read: FDA panel approves Acadia’s Parkinson’s disease treatment - BioPharma DIVE The Sandoz unit of Novartis A asked FDA to reject a Citizen’s Petition from AbbVie Inc. requesting that biosimilar ... a federal court injunction against competitor Repro-Med Systems to keep the company from selling home infusion ...
03/29/16 02:59 PMFDA warns RMS Medical against selling 'adulterated' and 'misbranded' pumps and needle sets - SACRAMENTO, Calif., March 29, 2016 /PRNewswire/ -- California-based medical device manufacturer EMED Technologies Corp. is seeking a federal court injunction to stop competitor Repro-Med Systems Inc. (doing business as RMS Medical Systems) from selling ...
03/18/16 04:12 PMREPRO MED SYSTEMS INC Files SEC form 8-K, Other Events -
03/11/16 02:53 PMSpectraScience Inc : Markets: Investors Looking Toward Renewed Momentum - Research on SpectraSCIENCE, Blue Sphere, Repro-Med Systems and Inpex - Further, the stock is trading at a price to sales ratio of 40.99. - Repro Med Systems Inc.'s stock increased by 1.33% to close Thursday's session at USD 0.38. The company's shares fluctuated in the range of USD 0.34 and USD 0.41. A total of 0.08 million ...
03/09/16 10:56 AMRepro Med Systems, Inc. Responds to FDA Warning Letter - [Business Wire] - Repro Med Systems, Inc. dba RMS Medical Products , a leading developer and manufacturer of medical devices and supplies, announced that on February 26, 2016, RMS Medical Products, Inc.
02/24/16 05:15 AMREPRO MED SYSTEMS, INC. Company Profile - Repro-Med Systems (aka RMS Medical Products) doesn't want to repo your medical devices, it wants to supply you with them! The company manufactures portable medical devices for respiratory and infusion therapy. Most of RMS' products are designed for ...
01/20/16 10:18 AMRepro-Med Systems, Inc. Earnings Analysis: Q3, 2016 By the Numbers -
01/13/16 12:04 PMREPRO MED SYSTEMS INC Financials -
01/08/16 01:03 PMREPRO MED SYSTEMS INC Files SEC form 10-Q, Quarterly Report -
12/23/15 06:16 AMREPRO MED SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Stat -
12/23/15 06:00 AMRepro Med Systems, Inc. Posts Strong Revenue Growth, Productivity Gains and Announces New Interim Chief Operating Officer - [Accesswire] - CHESTER, NY / ACCESSWIRE / December 23, 2015 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) announced that its net revenues for the third quarter ended November 30 for fiscal 2016 increased ...
10/23/15 01:43 PMREPRO MED SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers -
10/08/15 09:32 AMRepro-Med Systems, Inc. Earnings Q2, 2016 -
09/30/15 01:56 PMRepro Med Systems Announces Share Buyback - [Accesswire] - CHESTER, NY / ACCESSWIRE / September 30, 2015 / REPRO MED SYSTEMS, INC. (OTCQX: REPR) announced today that its Board of Directors has authorized a stock repurchase program pursuant to which the Company ...
09/30/15 12:12 PMRepro Med Systems, Inc. Posts Strong Revenue Growth and Productivity Gains - [Accesswire] - CHESTER, NY / ACCESSWIRE / September 30, 2015 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) announced that its second quarter net revenues for fiscal 2016 increased 26.4% over the previous ...
09/18/15 06:30 AMRepro Med Systems, Inc. Qualifies To Trade On OTCQX Market - [Accesswire] - CHESTER, NY / ACCESSWIRE / September 18, 2015 / Repro Med Systems, Inc., dba RMS Medical Products (OTCQX: REPR ), a manufacturer of medical devices for the ambulatory (home and institution) infusion market, ...
09/18/15 06:00 AMOTC Markets Group Welcomes Repro Med Systems to OTCQX - [PR Newswire] - NEW YORK, Sept. 18, 2015 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets, today announced Repro Med Systems, Inc. (OTCQX: REPR), a ...
05/08/15 03:58 PMREPRO MED SYSTEMS INC Files SEC form 10-K, Annual Report -
About Repro-Med Systems

REPRO MED SYSTEMS, INC., (REPRO MED) is engaged in designing, manufacturing and marketing medical devices for the ambulatory infusion market and emergency medical applications. The Company's products include FREEDOM60 Syringe Infusion System, RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), and RES-Q-VAC Portable Medical Suction System. The FREEDOM60 Syringe Infusion System (FREEDOM60) consists of the FREEDOM60 Syringe Infusion Pump and RMS Precision Flow Rate Tubing. It is designed for ambulatory medication infusions. The RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo) are designed for self-administration of medicine under the skin. The RES-Q-VAC Portable Medical Suction System is a hand-operated suction device that removes fluids from a patient's airway by attaching the RES-Q-VAC pump to sterile and non-sterile single-use catheters sized for adult and pediatric suctioning.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: REPR
  • CUSIP:
Key Metrics:
  • Previous Close: $0.35
  • 50 Day Moving Average: $0.34
  • 200 Day Moving Average: $0.39
  • P/E Ratio: 17.50
  • P/E Growth: 0.00
  • Market Cap: $13.29M
  • Current Quarter EPS Consensus Estimate: $N/A EPS
Additional Links:
Repro-Med Systems (NASDAQ:REPR) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha